MaaT Pharma
Created in 2014
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
556 1,413 13,977Activities
Technologies
Entity types
Location
70 Av. Tony Garnier, 69007 Lyon, France
Lyon
France
Employees
Scale: 51-200
Estimated: 83
SIREN
808370100Engaged corporates
36
14 31Added in Motherbase
5 years, 2 months ago
biotech Value proposition
The leading microbiome company in oncology
MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spear-head microbiome treatment integration into clinical practice.
Hervé Affagard, CEO & Co-founder
Microbiome, Microbiota, Microbiology, pharma, GvHD, Leukemia, Dysbiosis, Symbiosis, Biotech, oncology, cancer, gut microbiota, allo-HSCT, and Gut microbiomeOriginal language
The leading microbiome company in oncology
MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spear-head microbiome treatment integration into clinical practice.
Hervé Affagard, CEO & Co-founder
MaaT Pharma - Building a leading microbiome company in oncology
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
https://www.maatpharma.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Wolters Kluwer IT services, Information Services | Wolters Kluwer IT services, Information Services | Other 5 Mar 2023 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Apr 2019 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 7 Nov 2022 | | |
 La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | Other 7 Oct 2022 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 29 Oct 2023 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 26 Aug 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 22 May 2024 | | |
 Apec - Association Pour l'Emploi des Cadres Human ressources, Human Resources Services | Apec - Association Pour l'Emploi des Cadres Human ressources, Human Resources Services | Other 4 Jan 2023 | | |
 Inria Research, Research Services | Inria Research, Research Services | Not capitalistic Partnership Event 23 Jul 2019 | | |
 Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Not capitalistic Partnership Not event 24 Jan 2022 26 Aug 2024 | | |